TIDES Europe 講演者

Afaf El-Sagheer, PhD

Assistant Professor

University of Southampton

Alaric Desmarchelier, PhD

Business Development Manager - Peptides

Almac Group

Alexander Kleinsmann, PhD

Director R&D, CMC Development

Bachem AG

Ammar Ahmed, PhD

Senior Scientist, Chemical Development

AstraZeneca

Anja Hoeg

Entrepreneur

Smartrna

Anne Conibear, BSc(Hons) MSc PhD

Assistant Professor, Peptide and Protein Chemistry

Technische Universität Wien

Armin Delavari, PhD

Senior Scientist, ASO Purification Process Development

Biogen

Ashish Sarode, PhD

Director, Delivery & Formulations, mRNA Center of Excellence

Sanofi

Beatriz De La Torre, Ph.D.

Research Professor, Laboratory of Medicine and Med

University Of KwaZulu-Natal

Bhavani Prasad Vinjamuri, Ph.D

Scientist II

Biogen

Brenno Masina

Senior Graduate Student

ETH Zurich

Brian Dooley

Pharmaceutical Quality Senior Specialist

European Medicines Agency

Bruce Morimoto, PhD

Independent Consultant

TIDES Advisor

Chris Chorley

Regulatory Program Director

Roche

Chris Oswald

Founder, Owner, and Principal Consultant

Coswald Consulting LLC

Christoph Schmoelzer

Head of Product Management, Advanced Therapies

Thermo Fisher Scientific

Dr. Claudia Höbartner, Ph.D.

Professor of Organic Chemistry

University of Würzburg

Covadonga Paneda, PhD

Chief Development Officer

Altamira Therapeutics

Dr. Daniel Waschke, PhD

Associate Regulatory Program Director

F. Hoffmann-La Roche Ltd.

David Craik, PhD

Professor of Biomolecular Structure

University of Queensland

David Entwistle, Ph.D.

Senior Director, Technical Client Services

Codexis

Dr Gilles Divita

Founder and CEO

Divincell

El Djouhar Rekaï, PhD

Process & Analytical Development Director at PolyPeptide Group

PolyPeptide Group

Eleonora Marino

Pharmaceutical Quality Specialist

European Medicines Agency

Fabio Macciardi, MD, PhD

Chief Scientific Officer

Cognigenics

Federico Di Chiaro

Senior CMC Project Manager

Zealand Pharma

Fernando Albericio, Ph.D

Research Professor

University of Kwazulu-Natal

Gregoire Menoud

Senior PhD student

EPFL

Hannah Bolt, PhD, MBA

Head of Peptide Discovery

AstraZeneca

Dr. Holger Stalz, PhD

LCMS Product Specialist

Agilent Technologies

Jacob Challand Kofoed, PhD

Senior Principal Scientist, Peptide Research

Novo Nordisk A/S

Jacques Dumas

Chief Scientific Officer

Arrakis Therapeutics

Joanna Hemming Taylor, PhD

Associate Principal Scientist

AstraZeneca

John McCafferty, PhD

Chief Technology Officer

Maxion Therapeutics

John-Sigurd Svendsen, PhD

Founder and Chief Scientific Officer

Amicoat

Judit Tomsen Melero, PhD

Preclinical Project Manager

noctuRNA Therapeutics

Karunakar (Karu) Sukuru, R.Ph., Ph.D

Global Vice President, Pharma Product Development and Head, Scientific Advisory

Catalent

Kieren Mather, MD

Associate VP-Medical-Incretins and Diabetes Breakthroughs, Early Clinical Research

Eli Lilly and Company

Lin Chen, PhD

Associate Vice President, Peptide Manufacturing Technology and R&D

Asymchem

Lluís Riera-Ponsatí, PhD

Director of Preclinical Development

Neumirna Therapeutics

Louis Diorazio, PhD

Senior Principal Scientist, New Modalities

AstraZeneca

Louise Thorstholm

Senior Analytical Project Manager

Novo Nordisk

Lucas Bethge, Ph.D.

VP, Group Leader Chemistry

Silence Therapeutics

Luis Garcia

Président

SQY Therapeutics

Maged Darwish, PhD

Vice President, Global Regulatory Affairs, CMC

Alnylam Pharmaceuticals

Marc Jacob, PhD

Head of Strategic Development, Chromatography Products

YMC America

Dr Margot Pont, PhD

VP Translational Development

Integra Therapeutics

Mark Eccleston

CEO

ValiRx

Mark Frigerio

Vice President, Head of Platform Technology & Science

Bicycle Therapeutics

Martina Niess

Scientist

F. Hoffmann-La Roche Ltd

Mathias Wendt, PhD

Senior Peptide Chemist

Priavoid GmbH

Mathieu Cinier

Chief Scientific Officer

Affilogic

Michael Kopach, PhD

Associate Vice President, Synthetic Molecule Design and Development

Eli Lilly and Company

Mimoun Ayoub, PhD

Senior VP, Global Head of Peptide and Oligonucleotide Platforms

CordenPharma International

Monika Papayova

EPSRC Doctoral Prize Research Fellow

University of Southampton

Monika Papworth, PhD

Principal Scientist, Biologics Engineering

AstraZeneca R&D

Nenad Svrzikapa, DPhil

Co-Founder, Head of Oligonucleotide Platform

Orfonyx Bio

Nicolo Zuin Fantoni, PhD

Senior Scientist, Oligonucleotides

F. Hoffmann-La Roche Ltd.

Pachamuthu Kandasamy, PhD

Vice President, Medicinal Chemistry

Wave Life Sciences

Peter Hagedorn

Senior Director, Head of Bioinformatics

Contera Pharma

Poul Sorensen

CEO

Inverna therapeutics

Ralph Koitz

Head of Digital Manufacturing & Data Analytics

Bachem

Dr. Riccardo Bernasconi, Ph.D.

Director Business Development

Bachem

Robert Hagopian

Global Director, Biotech Partnerships

PolyPeptide Group

Robert Place

Chief Technology Officer

MiNA Therapeutics Limited

Dr. Sergey Tsukanov, PhD

Senior Director Chemistry

Eli Lilly and Company

Shanthi Ganesh

Director

Novo Nordisk

Shubhadra Pillay, PhD

Solutions Product Manager

Bruker BioSpin

Dr. Sonja Merkas, PhD

Founder and CEO

Livinovea

Sriram Sathy, Ph.D.

Chief Scientific Officer

AIRNA

Stefan Hyde

Automation Manager

Asahi Kasei Bioprocess America

Dr. Stefan Lutz, PhD

Chief Scientific Officer

Codexis

Stephanie Coffin

Global Peptide Drug Substance Steward

Eli Lilly

Dr Stephany Standley

Vice President, Oligonucleotide Synthesis and Chemistry

Wave Life Sciences

Thomas Müller-Späth, PhD

CEO

ChromaCon AG

Thomas Rupp

Vice President, CMC Strategy

Axolabs Berlin GmbH

Tobias Kapp, PhD

Global Head of Peptide Development

CordenPharma

Tracey Burr, Ph.D.

Executive Director, CMC Regulatory Affairs

Ionis Pharmaceuticals

Troels Koch, PhD

Chief Technology Officer

Cora Biosciences

Victoire Laude

Innovation Scientist

PolyPeptide Laboratories

Wuming Yan

Chief Scientist Oligonucleotides

Asymchem

Yogesh Sanghvi, PhD

President

Rasayan Inc.

Sophie Corbet

Bioprocessing Technical Service Manager

DuPont

Paul Nioi, PhD

SVP

Alnylam Pharmaceuticals, Inc.